Collins Stewart
http://www.collins-stewart.com/index.aspCollins Stewart is an independent investment banking group.
View Older Stories View More Recent Stories
-
Collins Stewart Maintains a 'Buy' on Human Genome Sciences (HGSI); Mgmt Dinner & Physician Feedback
-
Analysts Raise Estimates on NetApp Inc. (NTAP) Following Strong Q4 Earnings, Future Looks Promising
-
Q4 Preview: Like EMC (EMC), NetApp (NTAP) Likely to See Strong Storage Demand
-
Collins Stewart Cuts Price Target and Estimates on JinkoSolar Holding (JKS), Recent Checks Indicate Weak Market Trends
-
Collins Stewart Raises Price Target on BMC Software (BMC), Rising Margins and Revenues Lead to Larger Buyback Plans
-
Collins Stewart Downgrades Suntech Power (STP) to Neutral; Reducing CY11-12 Estimates on Lower Volumes and ASP
-
Collins Stewart Downgrades Hewlett-Packard (HPQ) to Neutral on Cloudy Outlook
-
Collins Stewart Cuts Price Target on LDK Solar (LDK), Maintains Sell Rating and Calls FY11 Revenue Guidance Optimistic
-
Collins Stewart Maintains a 'Buy' on Human Genome Sciences (HGSI); Color on Additional Payor Coverage for Benlysta
-
Collins Stewart Adjusts Price Target and Estimates on SunPower (SPWRA) To go Inline with Company's Outlook
-
Collins Stewart Reiterates a 'Buy' on Symantec (SYMC); Best Bookings Growth in 5 Years
-
Wall Street Pans Microsoft's (MSFT) Skype Deal
-
Microsoft (MSFT) Leverages International Cash in Skype Deal
-
Collins Stewart Raises Price Target on Diodes (DIOD) Following Solid Q1 Results and Q2 Guidance
-
Collins Stewart Upgrades Leap Wireless (LEAP) to Buy; A Large Step In The Right Direction
-
Collins Stewart Downgrades First Solar (FSLR) to Neutral; Strong Quarter, but Overwhelmed by Poor Near-term Outlook
-
Q1 Preview: First Solar (FSLR) May See Impact from Subsidy Cuts, But Not Yet
-
Collins Stewart Reiterates a 'Buy' on Valeant Pharmaceuticals (VRX); Weakness Related To CEPH Is A Good Buying Opportunity
-
Collins Stewart Cuts Price Target on Akamai Tech. (AKAM), Slowing Margins and Rising Competition
-
Collins Stewart Raises Price Target on BioMarin Pharmaceutical (BMRN) Following Solid Q1 Results and Q2 Guidance
-
Q1 Preview: Microsoft (MSFT) Just May Have IT for Solid Quarter
-
Q1 Preview: Lower Upgrades/Churn Should Benefit Sprint (S)
-
Collins Stewart Raises Estimates on VMware (VMW) Following Strong Q1 Results
-
Collins Stewart Sees IBM (IBM) on Track for a $20 EPS in 2015
-
Q1 Preview: AT&T (T) iPhone Loss Already Priced In, Wireline Still Bleeding
-
Collins Stewart Cuts Price Target on Dolby Laboratories (DLB), Weak End Markts Across The Board
-
Collins Stewart Maintains a 'Neutral' on Dell (DELL); Weak PC Rev Offset by Margins
-
Collins Stewart Downgrades Shire plc (SHPGY) to Sell
-
Collins Stewart Reiterates a 'Buy' on Human Genome Sciences (HGSI); Benlysta Poised for a Solid Launch
-
Collins Stewart Raises Price Target on Liberty Starz (LSTZA), Higher FY11 Subscriber Estimate
-
Collins Stewart Maintains a 'Buy' on First Solar (FSLR); President of Operations Resigns
-
Collins Stewart Raises Price Target on Perrigo Co. (PRGO) Following The Lift of a FDA Warning Letter
-
Collins Stewart Raises Price Target on Endo Pharmaceuticals (ENDP) Following Acquisition Talk of American Medical Systems (AMMD)
-
Collins Stewart Starts Almost Family (AFAM) at Neutral
-
Collins Stewart Starts LHC Group (LHCG) at Neutral
-
Collins Stewart Starts Amedisys (AMED) at Neutral
-
Collins Stewart Reiterates a 'Buy' on Intuitive Surgical (ISRG); Incremental Positive News for da Vinci Colorectal
-
Wall Street Mixed On Additional Upside in Cephalon (CEPH) Following Takeover Bid
-
Canaccord Genuity Morning Coffee on BP (BP): ’Cause You Had A Bad Day
-
Notable Analyst Rating Changes 03/29: (WAG) (BWC) (MAR) Upgraded; (BP) (ATPG) (PM) Downgraded
-
BP (BP) Shares Drop as Cost from Spill Could Surge on Manslaughter Charges
-
Collins Stewart Cuts BP (BP) to Sell; Stock Tumbling in Pre-Open Trade
-
Collins Stewart Starts Dendreon (DNDN) at Buy; Diligence Suggests Robust Demand and Positive NCD for Provenge
-
Notable 52-Week Highs and Lows of the Day 03/28: (ALU) (LULU) (PCS) High; (CBEH) (FUQI) (CISG) Low
-
Notable Analyst Rating Changes 03/28: (NOK) (NVDA) (ALU) Upgraded; (BTU) (CISG) (MAR) Downgraded
-
Collins Stewart Starts MetroPCS (PCS) at Buy; Proposed T-Mobile USA Acquisition Opens Door For More
-
Collins Stewart Starts Leap Wireless (LEAP) at Neutral; Value Segment Generates Value
-
Q3 Preview: Exdata, Currencies Likely to Push Oracle (ORCL) Above Views
-
Jabil (JBL) Beats Q2 Expectations, Issues Strong Q3 Outlook; Analyst Weigh In
-
Collins Stewart Raises Price Target on Kinetic Concepts (KCI), Tops Firms NPWT Survey

